FDA Inspection 1272362 — Midwest Transplant Network

Midwest Transplant Network — FEI 3001238375

The FDA completed an inspection of Midwest Transplant Network on April 25, 2025 in Westwood, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 25, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Westwood, KS (United States)